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Abstract 
The objective of this study was to evaluate the efficacy of two non-antibiotic treatment options for digital 
dermatitis (DD) in an organic certified dairy farm. A randomized clinical trial was conducted using 70 
multiparous Holstein cows with an early DD lesion at a USDA certified organic dairy farm in Northern 
Colorado, USA. Cows were enrolled in the study based on the presence of early DD lesions (scores M1 
and M2) and randomly assigned to one of three treatments: (1) topical application of copper sulfate and 
iodine (CUI); (2) topical application of honey and iodine (HOI); and (3) control subject to no treatment 
(CON). Cows were evaluated at enrolment and on days 3, 12, 28, and 120 post treatment for pain and 
lesion size and received a locomotion and a lesion score. Cure was defined as the transition from active 
to non-active stages (M1/M2 to M0 or M4). 
The formulations had variable effects on the treatment of DD. The cure rate was numerically higher for 
CUI on all follow up days. The proportion of cows experiencing pain on d3 after treatment was greater in 
CON, followed by HOI and CUI. However, this proportion increased in HOI during the follow up period. The 
CUI group had a greater reduction in lesion size and larger lesions persisted in HOI. Non-antibiotic 
treatment formulations were partially effective in the treatment of DD in organic dairy cows: The two non-
antibiotic formulations resulted in an earlier transition to mature lesions compared with the control group. 
The CUI combination was the most effective treatment in reducing lesion size, pain, and lameness in 
affected cows. However, this combination had short-term efficacy, which did not persist throughout the 
duration of the study. The HOI combination produced only transient reduction in lesion size. 
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 Digital dermatitis is a painful condition that can result in lameness and decreased 
performance. 
 Two non-antibiotic formulations resulted in earlier transition to M0 lesions than no 
treatment 
 A copper sulphate and iodine combination was most effective in reducing lesion size, 
pain, and lameness  
 A honey and iodine combination reduced lesion size but effects were transient.   
 
Abstract 
 The objective of this study was to evaluate the efficacy of two non-antibiotic treatment 











was conducted using 70 multiparous Holstein cows with an early DD lesion at a USDA certified 
organic dairy farm in Northern Colorado, USA. Cows were enrolled in the study based on the 
presence of early DD lesions (scores M1 and M2) and randomly assigned to one of three 
treatments: (1) topical application of copper sulfate and iodine (CUI); (2) topical application of 
honey and iodine (HOI); and (3) control subject to no treatment (CON). Cows were evaluated at 
enrolment and on days 3, 12, 28, and 120 post treatment for pain and lesion size and received a 
locomotion and a lesion score. Cure was defined as the transition from active to non-active 
stages (M1/M2 to M0 or M4). 
 
The formulations had variable effects on the treatment of DD. The cure rate was 
numerically higher for CUI on all follow up days. The proportion of cows experiencing pain on 
d3 after treatment was greater in CON, followed by HOI and CUI. However, this proportion 
increased in HOI during the follow up period. The CUI group had a greater reduction in lesion 
size and larger lesions persisted in HOI. Non-antibiotic treatment formulations were partially 
effective in the treatment of DD in organic dairy cows: The two non-antibiotic formulations 
resulted in an earlier transition to mature lesions compared with the control group. The CUI 
combination was the most effective treatment in reducing lesion size, pain, and lameness in 
affected cows. However, this combination had short-term efficacy, which did not persist 
throughout the duration of the study. The HOI combination produced only transient reduction in 
lesion size.  
 












Digital dermatitis (DD) is a contagious, painful, wart-like disorder of the digits of dairy 
cows, characterized as a superficial inflammation of the skin (Berry et al., 2012). Although the 
precise etiology of this disease is unknown, DD is considered a multifactorial polybacterial 
condition, with Treponema spp. being the most commonly isolated pathogens (Döpfer et al., 
1997; Krull et al., 2016). The prevalence of this disorder ranges from 15 to 49% in conventional 
dairy farms and has been estimated to be about 10% in organic dairy operations (Pinedo et al., 
2017; Solano et al., 2017). In a recent U.S. Department of Agriculture (USDA) survey, 31% of 
the farms with bred heifers and 75% of the operations with cows reported at least one case of 
DD, with higher percentages in medium and large dairies 1. As this is a painful condition, DD 
results in lameness and represents a serious concern due to decreased milk production and 
reduced welfare of dairy cows (Shearer et al., 2015; Biagiotti, 2016; Pinedo et al., 2017). 
Consequently, early detection and treatment are crucial for restoring digital function and cow 
comfort.  
 
Various antimicrobial formulations are available for the treatment of DD (Shearer et al., 
1998; Pol and Ruegg, 2007; Shearer et al., 2015). However, due to prohibitions in the use of 
antibiotics, organic dairy farms in the US face serious limitations in the administration of 
therapeutic resources and, consequently, non-antibiotic treatment options have been explored as 
alternatives for the treatment of DD lesions (Jacobs et al., 2018). The application of topical 
therapies under a bandage is the most common procedure for DD treatment in organic dairies 
                                                 
1 See: NAHMS, 2018. National Animal Health Monitoring System. Dairy 2014: Health and Management Practices 
on U.S. Dairy Operations, 2014. Fort Collins, Co: USDA APHIS Veterinary Services Centers for Epidemiology and 
Animal Health. https://www.aphis.usda.gov/animal_health/nahms/dairy/downloads/dairy14/Dairy14_dr_PartIII.pdf 











and poultices or emulsions are used to create ointments applied on the DD lesions (Biagiotti, 
2016; Pinedo et al., 2017). However, the efficacy of these preparations has not been fully 
investigated, and there is a need for scientific evidence regarding cure rates of DD lesions. 
Previous studies that tested products containing mixtures of soluble copper, a peroxide 
compound, and a cationic agent have demonstrated moderate efficacy in the treatment of DD 
lesions (Laven and Logue., 2006) and studies using copper sulfate, iodine, and honey suggest 
their potential for use in the treatment of DD (Durani and Leaper., 2008; Holzhauer et al., 2012; 
Oelschlaefel et al., 2012).   
 
In this study, two options for the treatment of DD lesions, using formulations prepared by 
combining copper sulfate, honey, and iodine were investigated. The hypothesis was that these 
formulations would range in effectiveness compared to no treatment. Therefore, the short- and 
long-term effects of two treatment formulations on lesion size, lesion score, pain response, and 
evidence of lameness were evaluated in organically managed dairy cows.   
 
Materials and methods 
Cows and housing 
 This study was conducted in a commercial USDA certified organic dairy herd in 
Northern Colorado.  The Institutional Animal Care and Use Committee at Colorado State 
University (Protocol number 17-7052A; Approval date, 28 February 2017 ) approved all the 
protocols prior to the initiation of the study. The protocol indicated that post-procedural 
monitoring should be performed on days 3, 12, 28, and 120 after treatment. This would assess 











observed at d12 examination. Control cows would be subject to early escape (prompt removal) if 
their clinical status worsens to a defined level (increasing 1 point in lameness score). Rescue 
treatment considered the application of therapy with copper sulphate and iodine. In addition, the 
whole herd (including control cows) went through preventive footbath with acidified 5% copper 
sulfate solution twice weekly. 
 
The study population consisted of 70 multiparous Holstein cows identified as having 
early DD lesions between April and June 2017. Cows did not have access to pasture during the 
study period. The dairy milked approximately 3,500 Holstein cows three times daily, with a 
rolling herd average of 8,600 kg/cow. All cows were housed in free stall barns with sand bedded 
stalls and had free access to a contiguous dry lot. Cows were fed a total mixed ration three times 
a day to meet or exceed the nutritional requirement for a lactating Holstein cow producing 30 
kg/d of milk with 3.5% fat and 3.1% true protein according to NRC (National Research Council, 
2001). Throughout the study period the diet consisted of corn silage (14 to 17.5%); wheat silage 
(13 to 20%); a premix containing soybean, soy hulls, whole cottonseed, corn, wheat, and 
minerals and vitamins (47.5 to 50.5%); sorghum silage (3.0 to 4.5%); alfalfa hay (12 to 16%); 
and grass hay (0 to 3%).  
 
Lameness management on the farm 
 The herd was regularly monitored for lameness by screening for lame cows by a trained 
hoof trimmer. Cows showing any sign of lameness were moved to the trimming chute and 
examined for the presence of specific conditions. The whole herd was surveyed for lameness 











months. The herd had a history of lameness cases associated with DD with an average 
prevalence of 10%, which was managed without the use of any antibiotics. The whole herd went 
through preventive footbath with acidified 5% copper sulfate solution twice weekly.  
 
Experimental procedures 
 A total of 70 cows were enrolled in the study. Cows were screened in the milking parlor 
using a flashlight and a mirror attached to a spatula to identify DD lesions. Additionally, cows 
were screened while in the headlocks, looking for pain in the area around the interdigital cleft of 
the hind feet. Cows with lesions suggestive of DD (n = 155) were taken to the trimming chute 
and further examined. Subsequently, DD lesions were categorized according to the M-scoring 
system ( Berry et al., 2011): M0, normal digit skin without signs of DD; M1, early, small, 
circumscribed red to grey lesions less than 2cm in diameter; M2, red or red grey, active, 
ulcerative lesions  > 2 cm in diameter; M3, healing stage where a firm scab like material has 
covered the DD lesions; M4, late chronic lesions that may have thickened epithelium or 
proliferative filamentous or scab like mass; M4.1, chronically affected foot that displays both M4 
and M1 stages. Only cows with M1 and M2 stage DD lesions in one hind foot were included in 
the study. If any other concurrent lesion was diagnosed during the initial checking, the cow was 
excluded from the trial. On day 0, before application of treatment, all cows were evaluated for 
pain and lesion size and received a locomotion and a lesion score. Pain scoring was based on 
pressure algometry (Millman, 2013) defined as the cow’s response to firm pressure with one 
thumb in the center of the lesion (approximately 50 N/cm2; Hernandez et al., 1999; Holzhauer et 
al., 2008). The responses were recorded as a number that ranged from 0 to 2 (0, no signs of pain; 











variable using a standard measuring ruler to report the largest diameter of the lesion (Hernandez 
et al., 1999).  Cows were evaluated for locomotion with a scoring system (Sprecher et al., 1997) 
on a scale from 1 to 5 (1, stands and walks normally with a level back; 2, stands with flat back 
but arches when walks, abnormal gait; 3, stands and walks with an arched back and short strides; 
4, arched back standing and walking, favors one or more limbs but can still bear some weight on 
them; 5, pronounced arching of back, reluctant to move, complete weight transfer off the 
affected limb. In addition, the type of lesion (early vs. mature) was recorded for all cows; early 
lesions were round to oval, flat or concave, raw, moist red-yellow to gray, and had tufted or 
granular strawberry like surfaces, whereas mature lesions were raised, with surfaces covered by 
small filiform papillae (Read and Walker, 1998).  
 
Two treatments were prepared at the beginning of the experiment. A total of 30 ml 7% 
Tincture Iodine (Triodine-7, Aspen Veterinary Resources) was mixed with 940 g copper sulfate 
to prepare a formulation that was applied to the copper sulphate iodine (CUI) group. Similarly, 
30 ml of iodine were mixed with 570 g of honey (Raw and Unfiltered Honey, Rice’s Lucky 
Clover Honey) to be applied to the honey iodine (HOI) group. The formulations were dispensed 
using standard measuring spoons. Each cow received an amount equivalent to 10 ml of the 
formulation in a clean paper towel that was applied topically in the lesion after thorough cleaning 
of the site with water and drying. Treatment paper towels were fixed in place using a foot wrap. 
The CON group had the lesion cleaned with water and, after drying, received a bandage without 
any treatment formulation along with regular after milking footbath containing acidified 5% 
copper sulfate solution. The treatment groups (CUI and HOI) received the treatment 













After initial evaluation on d0, cows were randomly assigned into one of the three 
treatment groups to receive a one-time treatment on the trimming chute, along with the 
functional hoof trimming by a trained hoof trimmer. The randomization was performed by 
random allocation of one of the three treatments to the first three animals brought to the study 
chute using Microsoft Excel (Microsoft Excel, Microsoft Inc.). Subsequently, the enrolled 
animals received their treatment following the same initial sequence. As the specific animals to 
be included in the study were not known in advance, a priori randomization of subjects into each 
treatment group was not possible. 
 
To maximize masking during the follow-up procedures, follow-up sheets did not include 
any information about the individual’s treatment group. In some cases, complete masking of the 
follow-up procedure was not possible due to the nature of the treatment (e.g. traces of blue color 
from copper sulphate in the CUI treatment). However, the follow-up protocol included objective 
variables that would be less influenced by the potential presumption of the treatment group. 
Cows were evaluated for pain and lesion size and received a locomotion score and a lesion score 
on d3, d12, d28, and d120 by one author that was masked to the treatment groups. Throughout 
the study period, all treatment groups were maintained under the same management and housing 
conditions and were fed identical rations. A subsample of 45 cows was followed up until d120, 
as some cows were not available at the time of assessment. All cows that completed the study 
remained on the farm after the trial was concluded. A total of 22 cows were moved to other units 











Overall, three cows left the herd for reasons not associated with their foot condition or adverse 
conditions related to this trial. 
  
Clinical cure rate was defined as the transition from active to non-active stages (M1/M2 
to M0 or M4) on each follow up day (Holzhauer et al., 2011; Jacobs et al., 2018). The difference 
in lesion size relative to d0 was defined as an outcome variable that provided an evaluation of the 
lesion progression relative to the day of enrollment to account for different proportions of 
M1/M2 lesions in each treatment group at enrollment.   
 
Statistical analysis 
 Data were entered into a spreadsheet (Microsoft Excel, Microsoft Inc.) and all analyses 
were conducted using statistical software (SAS Version 9.4, SAS Institute Inc,). Due to low 
number of cows in some response variable categories, categories were collapsed into binary 
outcomes; either presence or absence of pain (pain scores ≥ 1 considered painful [1], pain scores 
= 0 considered not painful [0]) and either lame or non-lame cows (locomotion scores > 2 
considered lame [1], locomotion score ≤ 2 considered not lame [0]). The FREQ procedure in 
SAS was used to compare proportions of categorical outcomes by treatment group, using chi 
squared test and Fisher’s exact test. Repeated measures analyses using MIXED procedure was 
used to evaluate continuous responses of lesion size and lesion difference. GENMOD procedure 
was used to model the categorical responses of pain and lameness. Repeated measures analyses 
using MIXED procedure were used to evaluate continuous responses (lesion size and lesion size 
difference), considering the effect of treatment group and the effect of follow up days. Logistic 















 A total of 70 cows were enrolled and allocated into CUI (n = 24), HOI (n = 23), and 
CON (n = 23) groups. Overall, 55% of the lesions were on the right rear foot and cows in CUI, 
HOI, and CON had 54%, 64% and 48% of the lesions in their right rear foot, respectively. Days 
in milk for cows in CUI, HOI, and CON were on average (±SD) 105±72 days, 128±57 days and 
126±53 days, respectively. Cows averaged 4.5 years old and were in 2nd parity (54.7%), 3rd 
parity (20.3%), and in parity ≥ 4 (24.9%). No significant differences were determined for DIM, 
age, and parity across treatment groups (Table 1). All cows started the experiment demonstrating 
pain. Percentages of cows determined lame at enrolment were 16.7%, 13%, and 13% in CUI, 
HOI, and CON, respectively.  
 
Response to treatment 
 The proportion of cows with M1 and M2 lesions decreased through the follow up period, 
as early lesions at the start of the study progressed to more mature lesions in all treatment groups. 
Lesions classified as M4.1 stage appeared on d28 in cows in HOI group, whereas in CON group 
M4.1 lesions appeared only on d120 (Fig 1). Remarkably, on d120 HOI group had a greater 
proportion of early than mature lesions (Fig 2).   
 
On day 3, the highest proportion of cows categorized as M0 was observed in CUI, 











decreased in HOI on consecutive follow up days (15, 13, and 11% on days 12, 28, and 120, 
respectively), indicating recurrence of the DD lesions in the cured cows. The proportion of M0 
lesions decreased on d12 in both CUI and CON, but we observed an increase in proportions of 
M0 lesions on day 28 and day 120 in both CUI and CON, indicating a greater percentage of cure 
in these groups. For both CUI and CON, the proportion of M4 lesions increased with follow up 
days until d28. However, at d120 a lower proportion of M4 lesions was determined (43 vs. 63 
and 53 vs. 64% in CUI and CON groups, respectively), possibly due to healing of the M4 lesions 
to M0 stage. In the HOI group, we observed a similar trend until d28; however, the proportion of 
M1 and M2 lesions was increased, indicating the reversion of these lesions from the M4 stage. 
 
All cows started the experiment demonstrating pain. When evaluating the pain response 
on d3, a greater proportion of cows evidenced pain in CON followed by HOI and CUI (P < 
0.01). However, on d12 a numerically greater proportion of cows in HOI group demonstrated 
pain, followed by CON and CUI. This trend continued until d28 and the difference among 
treatment groups was significant on d120 (P < 0.01; Table 2). The logistic regression analyses 
indicated that on d3, the odds (95% CI) of pain for cows in CUI were 0.04 (0.01-0.46) times the 
odds of pain for cows in CON. This odds ratio changed to 0.11 (0.01-0.95) on d3 follow up. 
Cows in HOI group had greater odds of pain than cows in CON starting on d28. On comparing 
the two topical treatments, CUI demonstrated lower odds of pain than HOI on all follow up days 
(Table 2). 
 
A significant effect for the interaction between treatment and day on the size of the lesion 











was 2.38 (±0.22) cm on the day of enrollment (d0) and decreased to 2.25 (±0.23) cm on d3, 2.04 
(±0.22) cm on d12, 2.27 (±0.23) cm on d28, and 1.19 (±0.28) cm on d120 (P< 0.01). Cows in 
HOI group started the study with 2.02 (±0.22) cm lesion size on average and the lesion changed 
to 1.69 (±0.23) cm, 1.79 (±0.24) cm, 2.23 (±0.23) cm, and 2.02 (±0.22) cm on d3, d12, d28, and 
d120, respectively. Cows in CON group had average lesion size of 1.7 (±0.22) cm on d0. The 
lesion size initially increased to 2.25 (±0.23) cm on d3, to change to 2.21 (±0.23) cm on d12, 
1.97 (± 0.23) cm on d28, and 1.27 (±0.29) cm on d120 (Fig 3).   
 
Accordingly, the difference in lesion size relative to d0 was associated with both 
treatment group and follow up day (P < 0.05). For CUI group the average change in lesion size 
was -0.25 cm on d3, -0.40 cm on d12, -0.09 cm on d28 and -1.19 cm on d120. For the HOI 
group, the average reduction in lesion size was -0.39 cm on d3, -0.23 cm on d12, but size 
increased on average by 0.19 cm on d28 and by 0.76 cm on d120. For CON group, the average 
change in lesion size was 0.59 cm on d3, 0.57 cm on d12, and 0.33 cm on d28 whereas the lesion 
decreased by -0.39 cm on d120 (Fig 4).  
 
Both HOI and CON groups evidenced an increase in the percentage of lame cows relative 
to enrolment. On d3, the greatest percentage of cows experiencing lameness was in CON, 
followed by HOI and CUI groups (P = 0.03). A similar trend was observed on d12 (P = 0.14), 
and d28 (P = 0.03), whereas on d120 HOI had greater proportion of cows demonstrating 
lameness, followed by CON and CUI (P = 0.01). On d3, the odds of lameness among cows in 












The cure rate of DD lesions, defined as the transition from active to non-active stages 
(M1/M2 to M0 or M4) on the day of follow up, was greatest in CUI on all follow up days, 
followed by HOI on d3 and d12 and CON on d28 and d120 (Table 4). On d12, the odds of cure 
for CUI cows were 4.13 (1.19-14.4) times the odds of cure for CON cows. However, on day 120, 
the odds of cure for cows in HOI were 0.14 times the odds of cure for cows in CON group 
(Table 4).  
 
Discussion 
Our results indicated that the non-antibiotic formulations tested in this study had variable 
effects on the treatment of DD lesions. Treatment group CUI had the smallest percentage of 
individuals experiencing pain until d12. However, this was a short-term effect and, by d28 and 
d120, the numerically small percentages of cows demonstrating pain were in CON. On the 
contrary, when compared to CON, HOI did not perform well in decreasing the pain response.   
 
When the regression of lesions was analyzed relative to d0, CUI performed better than 
HOI and CON. Lesion size differences for CUI were always negative, indicating that lesions on 
all follow up days were smaller than during enrolment. The average lesion size in CUI decreased 
after d0 across the follow up days except on d28, whereas in HOI group average lesion size 
decreased on d3 and increased on follow up d12 and d28. On the other hand, in CON group, 
average lesion size increased on d3 to start constantly decreasing on d12, likely due to the 
aforementioned augment in size evidenced in this group. However, in this group the difference in 











In CUI, a continued decrease in lesion size corresponded with negative lesion differences 
on all follow up days. In HOI, decrease in lesion size corresponded with a negative lesion 
difference on d3 but increased lesion sizes on d12, d28, and d120. Similarly, in CON, increased 
lesion sizes on d3 and d12 corresponded with positive lesion differences and decreased lesion 
size son d28 and d120 corresponded with smaller or negative lesion differences. 
 
Treatment group CUI had the smallest percentage of lame cows on all follow up days and 
it was the only treatment demonstrating statistical evidence of an advantage relative to CON 
early after treatment (d3).  However, the greatest long-term reduction on lameness was observed 
in CON group. 
 
Digital dermatitis lesions in bovines heal by second intention with granulation tissue 
formation (Shearer et al., 2015). Previous studies using one-time treatment with topical 
formulations have associated the bandage with a significant decrease in DD lesion score (Krull et 
al., 2016). Other studies have used gel paint (Holzhauer et al., 2011), and spray (Jacobs et al., 
2018) as treatment application methods. The technique used in our study, including the 
application of a bandage provided some protection from contamination and from treatment 
pharmaceuticals washing away, as reported in a previous study (Moore et al., 2001).  
 
Copper sulfate is a bacteriostatic agent that acts by reaction of Cu++ with protein thiol 
groups of pathogens and should be applied in a dilution to minimize the risk of burning the skin 
of cows (Epperson and Midla., 2007). We combined copper sulfate with iodine, which is an 











al., 2008). The antibacterial benefits of honey are related to its low pH, high osmolarity, and high 
peroxide activity (Oelschlaefel et al., 2012; Shearer et al., 2015). Since antibacterial activity in 
honey is primarily due to hydrogen peroxide that is produced by the action of glucose oxidase in 
honey, a higher concentration of honey causes cellular and protein damage by giving rise to 
oxygen radicals (Bang et al., 2003). To minimize this effect, we used the treatment formulation 
containing a combination of honey and iodine. Shearer and Hernandez (2000) tested a modified 
product that contained 2% of original peroxide concentration, 75% of the original concentration 
of copper and 200% of original cationic concentration. They reported this product to be more 
effective than commercial products and oxytetracycline in treating DD lesions. Commercial non-
antibiotic pastes containing copper and zinc sulfates, and sodium chlorides as an active 
ingredient have frequently been reported to be effective in the treatment of DD (Britt et al., 1996; 
Shearer and Hernandez., 2000; Moore et al., 2001).  
 
In another study conducted in 70 DD hooves (Oelschlaefel et al., 2012), the honey treated 
group demonstrated greater cure of lesions (40%) than the group that did not receive any 
treatment (8%). The study also concluded that using the honey product was associated with 
faster healing of lesions. This result is in agreement with our results, where we observed a 
similar cure rate for HOI (50% on d12). However, we observed a greater (31%) proportion of 
cured lesions in the CON group, which may be due to the footbath treatments that were not used 
in the study by Oelschlaefel et al. (2012).   
 
Clinical cure rate was defined as the transition from active to non-active stages (M1/M2 











healing that implies foot skin returning to an unaffected state (M0). Resolution to healthy foot 
skin is difficult to obtain (Krull et al., 2016); therefore a treatment option should be able to 
achieve a manageable state of disease by limiting the presence of an active lesion (Döpfer, 
2009). Consequently, the transition of the lesion score and the reduction of the lesion size should 
be considered relevant outcomes of DD control strategies.   
 
In a previous study by Shearer and Hernandez (2000), other non-antimicrobial 
formulations have been found to perform equally well compared to the antibiotic options. Apley 
(2015) reported that 5% copper sulfate solution healed 20% of the lesions. This formulation was 
received by CON in this experiment through the use of footbath, and the d28 outcome revealed 
73% cured lesions in our study. This discrepancy may be due to the difference in definition of 
healing and curing. Another factor could be the potential acidification of the footbath containing 
copper sulfate solution used in our study herd, leading to a higher cure rate. Iodine used in our 
study has previously been tested in the treatment of DD lesions as a spray with no effect on the 
prevalence of DD (Esch et al., 2000). However, we applied the formulation directly on the lesion 
that was subsequently covered with a bandage, which may have resulted in better outcomes in 
our study. Similar to the observations made in this study, Moore et al. (2001) reported that 28 
days after a single treatment with CUI, there were significantly reduced scores for pain and 
lesion size.  
 
Most of the conventional DD treatment studies commonly use tetracycline and 
oxytetracycline and consider a positive control group. Britt et al. (1996) and Shearer and 











of non-antibiotic formulations. However, as this study was conducted in a USDA certified 
commercial dairy herd, there was no opportunity for a positive control group. Britt et al. (1996) 
also investigated a placebo group treated with tap water spray, but due to ethical and cow welfare 
regulations, we provided the regular footbath to all treatment groups. Although our study was 
conducted in an organic dairy farm, up to 76% cure rates were achieved over 28 days. These 
results are similar to improvement rates obtained for either chlortetracycline or comparable 
oxytetracycline treatments (58% to 87%; Berry et al., 2010).  
 
Conclusions 
Non-antibiotic treatment formulations were reasonably effective in the treatment of DD 
in organic dairy cows. The two non-antibiotic formulations studied resulted in earlier transition 
to mature lesions compared with no treatment. The CUI combination was the most effective 
treatment in reducing lesion size, pain, and lameness in affected cows. However, this 
combination had short-term efficacy, which did not persist throughout the duration of the study. 
The HOI combination produced only transient reduction in lesion size. Therefore, CUI could 
represent a valid treatment option for digital dermatitis in organic dairy farms.   
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Fig. 1.  Distribution of digital dermatitis (DD) lesion score categories across different follow up 
days (day 0, day 3, day 12, day 28, day 120) after a single treatment with: A) formulation 
containing copper sulfate and iodine (CUI), B) honey and iodine (HOI), and C) non-treated 
control (CON). DD lesions were categorized according to M-scoring system: M0, normal digit 
skin without signs of DD; M, early, small, circumscribed red to grey lesions less than 2cm in 
diameter; M2, red or red grey, active, ulcerative lesions  > 2cm in diameter; M3, healing stage 
where a firm scab like material has covered the DD lesions; M4, late chronic lesions that may 
have thickened epithelium or proliferative filamentous or scab like mass; M4.1, chronically 




















































































Fig. 2.  Distribution of digital dermatitis (DD) lesion types across different follow up days (day 
0, day 3, day 12, day 28, day 120) after a single treatment with formulation containing: (A) 
copper sulfate and iodine (CUI); (B) honey and iodine (HOI); and (C) non-treated control 
(CON). DD lesions were categorized as early and matured lesions: early lesions were round to 
oval, flat or concave, raw, moist red-yellow to gray, and had tufted or granular strawberry like 




















































































Fig. 3. Mean ± standard error lesion size (cm) by treatment group across the follow up days. The 
solid line represents a group that received formulation containing copper sulfate and iodine 
(CUI; n = 24); the dotted line represents a group that received formulation containing honey and 
iodine (HOI; n = 23); broken line represents non-treated control group (CON; n = 23). Cows 
were followed on day 3, day 12, day 28 and day 120 after application of treatment.  
* Significantly (P < 0.05) different values on the day of follow up.  








Fig. 4. Mean ± standard error difference in size of lesions from the day of enrollment by 
treatment groups across the follow up days. The solid line represents a group that received 


































group that received formulation containing honey and iodine (HOI; n = 23); broken line 
represents control group (CON; n = 23). Cows were followed on day 3, day 12, day 28 and day 












































Demographics and lesion location at the time of study enrollment (baseline) for 70 Holstein cows 
that received a formulation containing copper sulfate and iodine (CUI), honey and iodine (HOI) 
and no treatment (CON).  
Parameters 
Treatment groups 
P CUI HOI CON 
n 24 23 23  
DIM 105.2±72 127.7±57 126.2±53 0.47 
Age at enrollment (years) 4.57±1.5 4.58±1.2 4.44±1.3 0.93 
Lactation number 2.95±1.4 2.73±0.9 2.75±1.2 0.81 
Lesion on right claw(n) 14 15 11  
Lesion on left claw(n) 10 8 12  















Proportion of cows with signs of pain after the application of treatment. The odds ratios for 
demonstration of pain by treatment group on different follow up days are presented. All cows 
started the experiment demonstrating pain. 
 
 
CUI, Cows that received formulation containing copper sulfate and iodine; HOI, Cows that 




Follow up days 
Day 3 Day 12 Day 28 Day 120 
CUI (%) 4/22 (18.2%) 4/23 (17.4%) 4/21 (19.1%) 1/14 (7.1%) 
HOI (%) 11/22 (50%) 10/20 (50%) 9/22 (40.9%) 10/18 (55.6%) 
CON (%) 13/21 (61.9%) 10/22 (45.5%) 4/22 (18.2%) 1/13 (7.7%) 
P 0.011 0.05 0.15 0.0003 
Odds ratio     











102.20 (2.76 -999) 
 



















Proportion of cows with signs of lameness (locomotion score≤ 2 not lame; locomotion score > 2 
lame) after application of treatment. The odds ratios for demonstration of lameness by treatment 
group on different follow up days are presented. Percentages of cows determined lame at 
enrolment were 16.7%, 13%, and 13% in CUI (formulation containing copper sulfate and 





Follow up days 
Day 3 Day 12 Day 28 Day 120 
CUI (%) 4/22 (18.2%) 5/23 (21.7%) 3/21 (14.2%) 2/14 (14.3%) 
HOI (%) 6/22 (27.3%) 7/20 (35%) 7/22 (31.8%) 8/18 (44.4%) 
CON (%) 11/21 (52.3%) 11/22 (50%) 4/22 (18.2%) 2/13 (15.4%) 
P 0.032 0.14 0.027 0.011 
Odds ratio     



































Proportion of cows evidencing cure of the lesions after application of treatment. The odds ratios 
for evidence of cure by treatment group on different follow up days are presented. 
 
CUI, Cows that received formulation containing copper sulfate and iodine; HOI, Cows that 




Follow up days 
Day 3 Day 12 Day 28 Day 120 
CUI (%) 7/22 (31.8%) 15/23 (65.2%) 16/21 (76.2%) 11/14 (78.6%) 
HOI (%) 6/22 (27.3%) 10/20 (50%) 14/22 (63.6%) 8/18 (44.4%) 
CON (%) 3/21 (14.3%) 7/22 (31.8%) 16/22 (72.7%) 10/13 (76.9%) 
P 0.38 0.08 0.64 0.005 
Odds ratio     
















CUI vs. HOI 1.21 (0.33-4.43) 
 
2.06 (0.59-7.06) 
 
1.93 (0.50-7.43) 
 
4.33 (0.95-19.63) 
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